{"id":"W4319216343","doi":"10.1016/j.ygyno.2023.01.020","title":"Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; McGill University Health Centre","funders":"ImmunoGen","keywords":"Medicine; Bevacizumab; Internal medicine; Ovarian cancer; Gastroenterology; Regimen; Oncology; Nausea; Adverse effect; Cancer; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007830286,0.0002876176,0.001175703,0.0002574484,0.0001974842,0.0006236382,0.0002471775,0.0005139195,0.0009162556],"category_scores_gemma":[0.001708059,0.0002355489,0.0008265018,0.0003418837,0.0003606951,0.0005020079,0.000143286,0.001488864,0.0002066619],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006967195,"about_ca_system_score_gemma":0.0005458089,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007308714,"about_ca_topic_score_gemma":0.001680402,"domain_scores_codex":[0.9995874,0.0001878075,0.00003719367,0.00006425421,0.00006664938,0.00005677027],"domain_scores_gemma":[0.9993375,0.0002062746,0.0001786893,0.00006031268,0.00005084483,0.0001663642],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.595682,0.007207613,0.07171597,0.0007881405,0.003384243,0.0008342296,0.0003773815,0.003852687,0.0482286,0.0002784739,0.001577263,0.2660735],"study_design_scores_gemma":[0.09309367,0.5099078,0.3405118,0.0001567879,0.004905971,0.003036832,0.000308048,0.0107454,0.02464151,0.0005600358,0.01201569,0.0001163601],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949309,0.003841174,0.0001377197,0.0001277736,0.00004397984,0.00004334087,0.0001296443,0.00001456832,0.0007308938],"genre_scores_gemma":[0.9985821,0.000637978,0.00008527585,0.00009895568,0.00003343494,0.00002030384,0.0001846195,0.000003832517,0.0003535621],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001175703,"threshold_uncertainty_score":0.00505507,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01050605846640505,"score_gpt":0.2844979034210637,"score_spread":0.2739918449546587,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}